SciDose, LLC
Patent Applications and Registrations
Patent applications and USPTO patent grants for SciDose, LLC.The latest application filed is for "formulations of vancomycin".
- SciDose, LLC - Amherst MA US
- SCIDOSE, LLC - Amhers MA US
- Scidose LLC -
| Patent | Date |
|---|---|
| Formulations of vancomycin Grant 10,864,250 - Palepu , et al. December 15, 2 | 2020-12-15 |
| Formulations Of Vancomycin App 20190336570 - Palepu; Nagesh R. ; et al. | 2019-11-07 |
| Formulations of vancomycin Grant 10,376,559 - Palepu , et al. A | 2019-08-13 |
| Formulations Of Vancomycin App 20170224767 - Palepu; Nagesh R. ; et al. | 2017-08-10 |
| Formulations Of Vancomycin App 20170202906 - PALEPU; Nagesh | 2017-07-20 |
| Formulations of vancomycin Grant 9,616,098 - Palepu April 11, 2 | 2017-04-11 |
| Formulations Of Vancomycin App 20160101147 - PALEPU; Nagesh R. | 2016-04-14 |
| Fulvestrant Formulations App 20160058773 - Palepu; Nageswara R. | 2016-03-03 |
| Enema composition for treatment of ulcerative colitis having long term stability Grant 9,238,037 - Palepu , et al. January 19, 2 | 2016-01-19 |
| Fulvestrant formulations Grant 9,180,088 - Palepu November 10, 2 | 2015-11-10 |
| Docetaxel formulations with lipoic acid Grant 8,912,228 - Palepu December 16, 2 | 2014-12-16 |
| Enema Composition For Treatment Of Ulcerative Colitis Having Long Term Stability App 20140323449 - PALEPU; Nagesh R. ; et al. | 2014-10-30 |
| Enema composition for treatment of ulcerative colitis having long term stability Grant 8,809,308 - Palepu , et al. August 19, 2 | 2014-08-19 |
| Enema Composition For Treatment Of Ulcerative Colitis Having Long Term Stability App 20140135299 - PALEPU; Nagesh R. ; et al. | 2014-05-15 |
| Fulvestrant Formulations App 20130267489 - Teja; Bulusu Bhanu ; et al. | 2013-10-10 |
| Docetaxel formulations with lipoic acid and/or dihydrolipoic acid Grant 8,541,465 - Palepu September 24, 2 | 2013-09-24 |
| Docetaxel formulations with lipoic acid Grant 8,476,310 - Palepu July 2, 2 | 2013-07-02 |
| Lyophilization process and products obtained thereby Grant 8,158,152 - Palepu April 17, 2 | 2012-04-17 |
| Solubilized formulation of docetaxel App 20110092579 - Palepu; Nageswara R. | 2011-04-21 |
| Docetaxel formulations with lipoic acid and/or dihydrolipoic acid App 20110092580 - Palepu; Nageswara R. | 2011-04-21 |
| Combinations of statins and anti-obesity agent App 20100239669 - Palepu; Negeswara R. | 2010-09-23 |
| Combinations of statins and anti-obesity agent App 20100234443 - Palepu; Nageswara R. | 2010-09-16 |
| Docetaxel formulations with lipoic acid Grant 7,772,274 - Palepu August 10, 2 | 2010-08-10 |
| Fulvestrant formulations App 20090227549 - Palepu; Nageswara R. | 2009-09-10 |
| Solubilized formulation of docetaxel without tween 80 App 20080319048 - Palepu; Nageswara R. ; et al. | 2008-12-25 |
| Alcohol free formulation of argatroban App 20080076798 - Palepu; Nageswara R. | 2008-03-27 |
| NCAGE Code | 60RM0 | SCIDOSE, LLC |
| CAGE Code | 60RM0 | SCIDOSE, LLC |
| DUNS | 618462381 | SCIDOSE, LLC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 